Engineering bacterial outer membrane vesicles as transdermal nanoplatforms for photo-TRAIL–programmed therapy against melanoma
Citations Over TimeTop 10% of 2020 papers
Abstract
Melanoma is an aggressive cancer with rapid progression, relapse, and metastasis. Systemic therapies for melanoma exhibit limited anticancer potential and high toxicity. Here, we developed the outer membrane vesicles derived from transgenic Escherichia coli, modified with αvβ3 integrin peptide targeting ligand and indocyanine green (named as I-P-OMVs), to induce the transdermal photo-TRAIL-programmed treatment in skin melanoma.-OMVs, which are outer membrane vesicles derived from transgenic Escherichia coli, modified with αvβ3 integrin targeting ligand and indocyanine green (named as I-P-OMVs), to induce the transdermal photo-TRAIL-programmed treatment in skin melanoma. I-P-OMVs exhibited excellent stratum corneum penetration and specificity to melanoma. Upon near-infrared irritation, I-P-OMVs not only induced photothermal-photodynamic responses against primary melanoma spheroids but also activated TRAIL-induced apoptosis in disseminated tumor cells, resulting in a complete eradication of melanoma. I-P-OMVs are the first nanoplatforms to induce transdermal photo-TRAIL-programmed therapy in melanoma with enhanced antitumor performance and high safety, having great potential in cancer therapy.
Related Papers
- → Studies on stratum corneum metabolism: function, molecular mechanism and influencing factors(2022)30 cited
- → Stratum Corneum Lipids Serve as a Bound-Water Modulator(1990)237 cited
- → Microneedle penetration and injection past the stratum corneum in humans(2008)45 cited
- → Correlation between Stratum Corneum/Water‐Partition Coefficient and Amounts of Flufenamic Acid Penetrated into the Stratum Corneum(2002)18 cited
- → Evaluation of the Stratum Corneum Exfoliated by Tape Stripping Method (No. 1)(1997)4 cited